AI in Genomics: From Research to Reality, Market to Reach $6.22 Billion
AI in Genomics: From Research to Reality, Market to Reach $6.22 Billion
According to this latest publication from Meticulous Research®, the global AI in genomics market is slated to register a CAGR of 42.8% during the forecast period 2022–2029 to reach $6.22 billion by 2029

The Artificial Intelligence in Genomics Market is expected to reach $6.22 billion by 2029, at a CAGR of 42.8% from 2022 to 2029.

Introduction to Genomics and Its Applications Genomics is the scientific study of genomes, the entire set of genes in an organism. Through various techniques, such as gene sequencing and mapping, scientists can decode and analyze these genomes. AI is increasingly being used in genomics for applications such as variant calling, genome annotation, variant classification, and genetic diagnosis. As technological advancements continue to make gene mapping more efficient, many companies are investing heavily in the potential of genomics to revolutionize fields such as drug discovery, diagnostics, and precision medicine.

Download Sample Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5345 

Broader Applications of Genomic Research The scope of genomic research is not limited to healthcare. It also has far-reaching implications in fields like biotechnology, agriculture, and social sciences. AI has become indispensable in this field, especially over the past few years, due to the enormous amount of data generated. According to the National Human Genome Research Institute, genomic research is projected to produce between 2 and 40 exabytes of data in the next decade. As DNA sequencing becomes more advanced, the complexity of the data increases, creating the need for sophisticated AI tools to help researchers analyze and interpret these vast datasets.

AI Transforming Genomic Data Into Clinical Insights AI can turn genomic data into clinically actionable insights, providing researchers and doctors with vital information that can help develop targeted therapies. AI’s ability to process massive amounts of data quickly is essential in genomics, where precision and speed are critical. These advancements allow for the creation of personalized treatment plans based on an individual's genetic makeup, revolutionizing the way we approach healthcare.

Key Developments in AI-Driven Genomics Several companies and organizations are working towards advancing AI’s role in genomics through significant funding initiatives. In March 2022, Illumina Accelerator invested in startups that are developing breakthrough technologies in areas like therapeutics, diagnostics, and DNA storage. NonExomics, one of the supported startups, is working on a platform that maps new drug targets from unexplored regions of the genome. DNAnexus, a cloud-based data analysis platform, secured $200 million to enhance its genomics platform using AI and machine learning. In France, SeqOne Genomics raised $23.66 million to fund AI-driven personalized genomic analysis solutions, while Canada-based Deep Genomics closed a $180 million funding round to advance AI therapeutics.

Trending Blog : https://meticulousblog.org/the-growing-synergy-between-ai-and-genomics-revolutionizing-medicine-and-beyond

Conclusion As AI continues to evolve, it is playing an increasingly important role in genomics. The combination of AI and genomics is expected to drive the AI genomics market to grow at a staggering CAGR of 42.8%, reaching $6.22 billion by 2029. The integration of AI into genomics research is transforming the future of healthcare, enabling innovations in personalized medicine and targeted therapies.

Key Players

The key players operating in the global AI in genomics market are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

Quick Buy : https://www.meticulousresearch.com/Checkout/40485578

About Meticulous Research®

Meticulous Research® is a leading provider of comprehensive market intelligence, offering actionable insights and analysis across various industries. Our reports empower businesses to make informed decisions, drive growth, and remain competitive in a rapidly evolving marketplace.

Contact:

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

 

 

disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations